Target intelligence / Profile preview

Immune system activity

Molecular classification
Other
01

Overview

Immune system activity refers to the collective physiological processes and responses orchestrated by the innate and adaptive immune systems to protect the host from pathogens, toxins, and malignant cells (NIH, 2023). It is not a single molecular target but rather a complex network of cellular interactions and signaling pathways involving various leukocytes, cytokines, and lymphoid organs (StatPearls, 2023). In a healthy state, immune activity maintains homeostasis through a balance of activation and regulation; however, dysregulation can lead to significant pathology. Overactive immune responses are central to autoimmune diseases and chronic inflammation, while suppressed activity increases susceptibility to infections and cancer (Janeway's Immunobiology, 2016). Pharmacological modulation of immune system activity is a cornerstone of modern medicine, utilizing immunosuppressants to treat transplant rejection and autoimmunity, or immunostimulants and checkpoint inhibitors to enhance anti-tumor responses. Because "immune system activity" encompasses thousands of distinct proteins and pathways, drug discovery focuses on specific molecular targets within this system, such as cytokines, G protein-coupled receptors, or kinases, rather than the activity as a monolithic entity.

Other names
Immune responseImmunological activityImmune functionHost defense
02

Mechanism of action

Modulation of immune system activity occurs through diverse mechanisms including the inhibition of pro-inflammatory cytokines, blockade of immune checkpoints, depletion of specific lymphocyte populations, or agonism of pattern recognition receptors (StatPearls, 2023).

03

Biological functions

Immune responseInflammationCellular homeostasisPathogen clearanceImmunological memory
04

Disease associations

Autoimmune diseaseInfectionCancerInflammationAllergyImmunodeficiency
05

Safety considerations

Increased risk of opportunistic infectionsCytokine release syndrome (CRS)Immune-related adverse events (irAEs)Secondary malignanciesHypersensitivity reactions (PubMed, 2022)
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Cytokine profiles (e.g., IL-6, TNF-alpha)Absolute lymphocyte countFlow cytometry markers (e.g., CD4/CD8 ratio) (NIH, 2023)

Beyond the preview

Go deeper on Immune system activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call